U.S. SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                   FORM 10-QSB



(X} QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
EXCHANGE ACT OF 1934

                  For the quarterly period ended March 31, 2002

{ }  TRANSITION  REPORT  PURSUANT  TO  SECTION  13 OR 15 (d)  OF THE
SECURITIES EXCHANGE ACT OF 1934

     For the transition period from ______________________________


                        Commission File Number: 000-27865

                             DISEASE SCIENCES, INC.
        (Exact name of small business issuer as specified in its charter)


               Delaware                               65-1095431
    (State or other jurisdiction of                 (IRS Employer
     Incorporation or organization)               Identification No.)


                620 Herndon Parkway, Suite 360, Herndon, VA 20170
                    (Address of Principal executive offices)


         Issuer's telephone number, including area code: (703) 563-6565

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15 (d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.) YES X NO_____

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date: 29,437,878 issued and
outstanding at March 31, 2002.


                             DISEASE SCIENCES, INC.
                    TO BE RENAMED ICEWEB COMMUNICATIONS, INC.

              QUARTERLY REPORT ON FORM 10-QSB FOR THE PERIOD ENDED
                                 MARCH 31, 2002

                                TABLE OF CONTENTS



                                                                        Page No.
PART I     FINANCIAL INFORMATION

Item 1     Financial Statements

           Unaudited Condensed Balance Sheet at March 31, 2002..........      3

           Unaudited Condensed Statements of Operations for the.........      4
           three months and six months ended March 31, 2002 and 2001

           Unaudited Condensed Statements of Cash Flows for the.........      5
           six months ended March 31, 2002 and 2001

           Notes to Unaudited Condensed Financial Statements............   6-13

Item 2     Management's Discussion and Analysis of Financial............  13-21
           Condition and Results of Operations


PART II    OTHER INFORMATION

Item 6     Exhibits and Reports on Form 8-K ............................     22

           Signatures ..................................................     22

                                       2


Item 1. Financial Statements

                             DISEASE SCIENCES, INC.
                    TO BE RENAMED ICEWEB COMMUNICATIONS, INC.
                                 March 31, 2002
                             CONDENSED BALANCE SHEET
                                   (UNAUDITED)

                                     ASSETS
Current assets:
  Cash ........................................................     $     9,419
  Accounts receivable .........................................          42,713
                                                                    -----------
    Total current assets ......................................          52,132
                                                                    -----------

Property and equipment, net ...................................         200,248

Due from related parties ......................................          84,857
                                                                    -----------
Total assets ..................................................         337,237
                                                                    ===========

                      LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
  Accounts payable ............................................     $   244,842
  Accrued expenses ............................................          28,762
  Payable to officer ..........................................         403,015
  Notes payable ...............................................          97,000
  Deferred revenue ............................................           5,000
                                                                    -----------
    Total current liabilities .................................         762,150
                                                                    -----------
Stockholders' deficit:
  Common stock, $.001 par value; 100,000,000
    shares authorized, 29,437,878 issued ......................          29,438
  Additional paid in capital ..................................       1,542,266
  Accumulated deficit .........................................      (2,013,087)
                                                                    -----------
    Total stockholders' deficit ...............................        (424,913)
                                                                    -----------

Total liabilities and stockholders' deficit ...................         337,237
                                                                    ===========
                   See notes to condensed financial statements

                                       3

                             DISEASE SCIENCES, INC.
                    TO BE RENAMED ICEWEB COMMUNICATIONS, INC.

                        CONDENSED STATEMENT OF OPERATIONS
               THREE AND SIX MONTHS ENDED MARCH 31, 2002 AND 2001
                                   (UNAUDITED)

                          Three Months Ended             Six Months Ended
                               March 31                       March 31
                          2002           2001           2002           2001
                      ------------   ------------   ------------   ------------
Revenues ...........  $     67,686   $        489   $    141,171   $        489

Cost of Sales ......        13,122          8,104         49,298          8,104
                      ------------   ------------   ------------   ------------
Gross Profit .......        54,563         (7,614)        91,873         (7,614)
                      ------------   ------------   ------------   ------------

Operating expenses:

  Marketing & sales         61,556         33,591        115,851         36,844

  Research & .......        16,995              0         43,042              0
  development

  General & ........        90,760         78,449        187,063        168,572
  Administrative
                      ------------   ------------   ------------   ------------
Operating loss .....      (114,746)      (119,655)      (254,082)      (213,031)
                      ------------   ------------   ------------   ------------

Interest (income)
expense, net .......            66          7,522          3,440          7,522

Loss on disposal of
assets .............         2,117              0          2,117              0

Depreciation and
amortization .......        22,866         21,957         49,412         41,857
                      ------------   ------------   ------------   ------------
Net loss ...........  $   (139,796)  $   (149,133)  $   (309,052)  $   (262,409)
                      ============   ============   ============   ============
Basic loss per
common share .......  $       (.01)  $       (.01)  $       (.01)  $       (.01)
                      ============   ============   ============   ============

Weighted average
common shares
outstanding ........    23,475,262     25,000,000     23,091,626     25,871,762
                      ============   ============   ============   ============

                See notes to condensed financial statements

                                       4

                             DISEASE SCIENCES, INC.
                    TO BE RENAMED ICEWEB COMMUNICATIONS, INC.

                        CONDENSED STATEMENT OF CASH FLOWS
                    SIX MONTHS ENDED MARCH 31, 2002 AND 2001
                                   (UNAUDITED)


                                                         2002            2001
                                                       ---------      ---------
NET LOSS .........................................     $(309,052)     $(262,409)

Adjustments to reconcile net loss to net
 cash provided by operating activities:
Depreciation & amortization ......................        49,412         41,857
Loss on disposal of assets .......................         4,910              -
Non-cash adjustments .............................        (2,020)             -
Changes in assets and liabilities:
  Increase in assets .............................        55,798        170,663
  Increase in liabilities ........................        78,976         34,164
                                                       ---------      ---------
NET CASH PROVIDED (USED) IN OPERATIONS ...........      (121,976)       (84,053)
                                                       ---------      ---------
CASH FLOWS FROM INVESTING ACTIVITIES
  Purchase of fixed assets .......................        (9,695)       (72,991)
  Proceeds from sale of fixed assets .............        10,000              -
                                                       ---------      ---------
NET CASH PROVIDED (USED) BY INVESTING ACTIVITIES .           305        (72,991)
                                                       ---------      ---------
CASH FLOWS FROM FINANCING ACTIVITIES
  Notes payable ..................................        97,000        (46,680)
  Proceeds from related party ....................        22,592        (25,697)
  Contributed capital ............................         3,986              -
  Proceeds from private offering .................             -        539,500
                                                       ---------      ---------
NET CASH PROVIDED (USED) BY FINANCING ACTIVITIES .       115,606        467,123
                                                       ---------      ---------

NET INCREASE (DECREASE) IN CASH ..................        (6,065)       310,078

CASH, beginning of period ........................        15,484         40,192
                                                       ---------      ---------
CASH, end of period ..............................         9,419        350,270
                                                       =========      =========

                 See notes to condensed financial statements

                                       5

                              Disease Science, Inc.
                    To be renamed Iceweb Communications, Inc.

Notes to Condensed Financials Statements unaudited

NOTE 1.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Financial Statements

The unaudited condensed financial statements have been prepared in conformity
with generally accepted accounting principles and include all adjustments which
are, in the opinion of management, necessary for a fair presentation of the
results for the interim periods presented. All such adjustments are, in the
opinion of management, of a normal recurring nature. The accounting entries to
record the merger with DSSC are included in the financial statements for the
second quarter of fiscal year 2002 (January 2002 through March 2002). Additional
information on the finances of Disease Sciences, Inc. and the merger can be
found in the Form 10-KSB filed May 16, 2002; the Form 8-K filed April 4, 2002
and the Form 8-K/A filed June 16, 2002.

The results of operations for the three months and nine months ended are not
necessarily indicative of those for the full year. In the opinion of management,
the accompanying unaudited financial statements contain all adjustments
necessary to fairly present the financial position and the results of operations
for the periods indicated.

Certain information and footnote disclosures normally included in condensed
consolidated financial statements prepared in accordance with generally accepted
accounting principles have been condensed or omitted. It is suggested that these
condensed consolidated financial statements be read in conjunction with the
financial statements and notes thereto included in the Company's annual report
on Form 10-KSB for the year ended January 31, 2001. As stated above, the Form
8-K and Form 8-K/A that contained information on the merger between Disease
Sciences, Inc. and Iceweb, Inc. should also be read.

On June 18, 2002, the Company filed a Form 8-K to change its fiscal year to
October 1 through September 30. The change takes effect immediately so that the
current fiscal year is October 1, 2001 through September 30, 2002.

Organization

Disease Sciences, Inc.(DSSC), is a Delaware corporation which anticipates
changing its name to Iceweb Communications, Inc. in the near future.

On March 21, 2002, Disease Sciences, Inc. executed an Agreement and Plan of
Merger (DSSC Agreement) with Iceweb Communications, Inc., a Delaware
Corporation and its shareholders.  Under the terms of the DSSC Agreement
Iceweb was acquired by and became a wholly owned subsidiary of DSSC.
Pursuant to the DSSC Agreement, each of the 22,720,500 share of common stock
of ICEWEB issued and outstanding immediately prior to the Merger were
converted into the right to receive 1.07 shares of

                                       6


restricted common stock of DSSC, for an aggregate of 24,311,000 DSSC Common
Shares. The source of the approximately 24,311,000 DSSC Common Shares being
exchanged for approximately 22,720,500 Iceweb Common Shares is as follows:
5,600,000 DSSC Common Shares were returned to the DSSC Treasury following the
redemption of DSSC Common Shares; and approximately 18,711,000 additional DSSC
Common Shares were issued from the DSSC Treasury. DSSC redeemed 5,600,000 Common
Shares from Dr. Goldstein and Brian Johns in consideration for (a) forgiveness
of $10,000 promissory notes owing by each to DSSC; and (b) payment of $55,000 by
DSSC to each of Goldstein and John.

Each of the 5,441,000 warrants to purchase ICEWEB Common Shares issued and
outstanding immediately prior to the Merger but not exercised were converted
into the right to receive one warrant to purchase 1.07 Common Shares upon
exercise of said warrant.

The 6,980,000 warrants to purchase DSSC Common Shares remain issued and
outstanding. None of said warrants has been exercised.

Options to purchase ICEWEB Common Shares issued and outstanding immediately
prior to the Merger but not exercised shall be converted into the right to
receive one option to purchase 1.07 Common Shares upon exercise of said options.

Giving effect to the recapitalization, the exchanging Iceweb Shareholders will
be the DSSC Controlling Shareholder after the Merger. DSSC will have a total of
29,460,935 shares of Common Stock issued and outstanding. The significant
shareholders with 5% or more or the shares are John R. Signorello with 61.7% or
the shares and Michael VanPatten with 5.12% of the shares. The closing of the
agreement has resulted in a change in control of Disease Sciences, Inc.

Concurrent with the closing of the DSSC Agreement, the pre-merger Directors and
Officers of DSSC were replaced by the Directors and Officers of Iceweb.

Cash Equivalents

The Company considers all highly-liquid debt instruments with original
maturities of three months or less to be cash equivalents.

Property and Equipment

Property and equipment is recorded at cost and is depreciated using the
straight-line method over their estimated useful lives.

Use of Estimates

The preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect certain reported amounts and disclosures.
Accordingly, actual results could differ from those estimates.

                                       7


Revenue Recognition

Generally, revenues from sales of products are recognized when products are
shipped unless the Company has obligations remaining under sales or licensing
agreements, in which case revenue is either deferred until all obligations are
satisfied or recognized ratably over the term of the contract. The company uses
the Percentage of Completion method to recognize revenue and expense from
contracts extending through fiscal quarters.

Intangible Assets

Trademarks were acquired in September 2000. They were recorded at cost and are
amortized using the straight-line method over 5 years. The Company continually
reviews its intangible assets to evaluate whether events or changes have
occurred that would suggest an impairment of carrying value. An impairment would
be recognized when expected future operating cash flows are lower than the
carrying value.

Advertising Costs

Advertising costs are included in selling expenses, and are expensed as
incurred.

Amortization of Goodwill

Goodwill represents the amount by which the purchase price of a business
acquired exceeds the fair market value of the net assets acquired under the
purchase method of accounting. The Company assesses whether its goodwill and
other intangible assets are impaired as required by SFAS No. 121, "Accounting
for the Impairment of Long-Lived Assets to be Disposed of," based on an
evaluation of undiscounted projected cash flows through the remaining
amortization period. If an impairment exists, the amount of such impairment is
calculated based on the estimated fair value of the asset. The Company
determined the goodwill associated with the acquisition of American Computer
Systems was impaired and the entire amount of goodwill, $257,081 and accumulated
amortization, $102,832 was written off in September 2001.

Recent Accounting Pronouncements

On June 29, 2001, the Financial Accounting Standards Board unanimously approved
the issuance of Statements of Financial Accounting Standards No. 141, Business
Combinations (Statement 141), and No. 142, Goodwill and Other Intangible Assets
(Statements 142). Statement 141 eliminates the pooling-of interests method of
accounting for business combinations except for qualifying business combinations
that were initiated prior to July 1, 2001. Statement 141 changes the criteria to
recognize intangible assets apart form goodwill. The requirements of Statement
141 are effective for any business combination accounted for by the purchase
method that is completed after June 30, 2001.

Under Statement 142, goodwill and indefinite lived intangible assets are no
longer amortized but are reviewed annually, or more frequently if impairment
indicators arise, for impairment. Identifiable intangible assets will continue
to be amortized over their estimated useful lives.

                                       8


Early adoption is permitted for companies with fiscal years beginning after
March 15, 2001, provided that their first quarter financial statements have not
been issued. The Company plans to adopt Statement 142 beginning January 1, 2002.
The adoption of Statement 142 is not expected to have a material impact on the
Company's earnings or financial position, since Goodwill was written down to $0
as of September 30, 2001.

NOTE 3 - PROPERTY AND EQUIPMENT

Property and equipment consist of the following:
                                                       2002             2001
                                                       ----             ----
Furniture and fixtures .....................        $  21,593         $   4,593
Computers and equipment ....................          177,961            92,988
Software ...................................           96,615
Automobiles ................................            3,600            17,737
Intangibles ................................            9,676            38,972
Leasehold improvements .....................            3,000            20,760
  Accumulated depreciation .................         (112,197)          (30,460)
                                                     --------           -------
Property and equipment, net ................          200,248           144,590
                                                     ========           =======
NOTE 4 - OPERATING LEASES

The Company leased facilities in Chantilly, VA for office space and
developmental work through May 2001 at a cost of $2,250 per month. From June to
September 2001 the Company occupied the Learning Stream office space at Silver
Spring, MD; the rental expense was paid by Learning Stream, Inc. From September
15, 2001 through April 30, 2002 the Company had a sublease on space in Herndon,
VA at a cost of $5,000 per month. The Company has extended its lease at its
current location for 24 months starting May 1, 2002 at an average cost of $6,933
per month.

NOTE 5 - ACCOUNTS RECEIVABLE

Accounts receivable consist of normal trade receivables. The Company assesses
the collectibility of its accounts receivable regularly. Based on this
assessment, an allowance against accounts receivable has been established for
$8,500.

NOTE 6 - RELATED PARTIES

For the period ended March 31, 2002, the company held Notes Receivable from a
corporation related through common ownership and separately from a shareholder
of the Company. At March 31, 2002 and 2001, the Company had a note receivable
from a shareholder of $81,652 and $137,127. This advance is non-interest bearing
and due on demand. The company advanced a corporation related through common
ownership $3,204 and $4,242 at March 31, 2002 and 2001 respectively. The advance
is non-interest bearing and due on demand.

During the years ended September 30, 2001 and 2000 a shareholder of the
corporation contributed capital of $2,280 and $886,191, respectively to help
fund operations.

The Company has a note payable for $403,015 due to a shareholder of the Company.
The note is described more fully below under NOTES PAYABLE.

                                       9


NOTE 7 - STOCK OFFERING

In July 2000, the Company commenced a stock offering under Regulation D. The
offering consisted of 10,000 units at $100 per unit, each unit contained 500
shares of common stock at a price of $0.20 per share. As of September 30, 2000,
no common stock had been issued, nor had any funds been received. As of
September 2001, approximately $539,500 was received and approximately 2,720,500
shares of common stock had been issued. Each share of common stock that was sold
was subsequently issued two warrants for each common share for a total of
5,441,000 warrants.

NOTE 8 - ACQUISITION

In June 2001, the Company executed an asset purchase agreement to purchase all
the assets of Learning Stream, Inc. which is in the same line of business as the
Company. The purchase price was $173,000, which approximates the fair value of
$72,000 of computer software and $101,000 of computer equipment acquired. The
acquisition was accounted for using the purchase method of accounting. The
results of operations are included in the financial statements from the date of
acquisition.

NOTE 9 - SHORT-TERM DEBT

The Company had a line of credit with Merrill Lynch Business Financial Services,
Inc. of up to $500,000. The interest rate charged was based on 30-day commercial
paper plus 2.4%. The interest rate was 5.07% and 8.96% as of September 30, 2001
and 2000 respectively. The line of credit was secured by the assets of the
Company, and was personally guaranteed by the majority shareholder. The line of
credit expired in January 2002 and was converted to a note payable to the
majority shareholder.

On May 23, 2001 Disease Sciences borrowed a total of $140,000 from two
unaffiliated third parties. The notes are unsecured, payable upon demand and
bear interest at 9% per year. In March 2002, payments totaling $50,000 reduced
the balance due to $90,000. The Company has accrued interest payable of $8,400
on these notes as of March 31, 2002.

In March 2002, a shareholder made a double payment of $7,000 to the Company for
the ongoing private placement. The amount due the shareholder has been recorded
as a note payable.

NOTE 10 - PRIVATE PLACEMENT

Disease Sciences, Inc. completed a private placement of 4,700,000 Units (the
"Units)" in August of 2001. Each Unit consisted of one share of common stock and
four common stock purchase warrants designated Series A, Series B, Series C and
Series D common stock purchase warrants (collectively the "Warrants"). The
Series A Warrant included in each Unit entitles the holder to purchase one share
of common stock of the Company at a purchase price of $.30 per share. The Series
B Warrant included in each Unit entitles the holder to purchase one share of
common stock of the Company at a purchase price of $.60 per share. The Series C
Warrant included in each Unit entitles the holder to purchase one share of
common stock of the Company at a

                                       10


purchase price of $1.00 per share. The Series D Warrant included in each Unit
entitles the holder to purchase one share of common stock of the Company at the
purchase price of $2.00 per share. The Warrants will expire on May 1, 2006. The
Company may call any Warrant series or all of the Warrants at a call price of
$.001 per underlying share should the Company's common stock trade at or above
$5.00 per share, based on the reported closing bid price of the common stock,
for 10 consecutive trading days following 15 days prior written notice of the
Company's intention to call the Warrants. In the event the Warrants or Warrant
series subject to call have not been exercised by written notice within such
15-day notice period, the Warrants will cease to exist.

The Company completed a second private placement of 1,822,500 units as of March
31, 2002. Each Unit consists of one share of common stock and three common stock
purchase warrants designated Series E, Series F and Series G Common Stock
Purchase Warrants (collectively, the "Warrants"). Each Series E Warrant entitles
the holder to purchase one share of common stock at a purchase price of $.75 per
share. Each Series F Warrant entitles the holder to purchase one share of common
stock at a purchase price of $1.50 per share. Each Series G Warrant entitles the
holder to purchase one share of common stock at a purchase price of $3.00 per
share. The Warrants are immediately exercisable and will expire on October 1,
2005. Upon 15 days written notice, the Company may call any Warrant series or
all of the Warrants at a call price of $.001 per underlying share should the
common stock trade at or above $5.00 per share for 10 consecutive trading days
prior to the date of such notice. The Company had sold 1,822,500 units as of
March 21, 2002. The Company received a double payment from one investor for
$7,000 in March 2002; the amount has been recorded as a Note Payable to the
investor for $7,000.

NOTE 11 - STOCK OPTIONS

During March 2002, the Company adopted the "Management and Director Equity
Incentive and Compensation Plan." The maximum number of shares authorized and
available under the plan is 10,000,000 shares. As of March 31, 2002, 2,675,000
of the shares authorized under the plan have been issued. Under the terms of the
plan, the options expire after 5 years, as long as the employees remain employed
with the Company. The following is a summary of option activity for the six
months ended March 31, 2002.

                                  Options           Options Outstanding
                                 Available                      Weighted Average
                                 For Grant        Options        Exercise Price
                                 ---------        -------        --------------
Beginning balance .............  10,000,000              -              -

Granted - DSSC ................   2,000,000
Granted .......................           -      2,675,000            .20
Exercised - DSSC ..............           -     (2,000,000)             -
Cancelled .....................           -              -              -
Balance, March 31, 2002 .......   5,325,000      2,675,000            .20

The employee option grants provide that the option will be canceled ninety days
after an employee leaves employment with the Company.

                                       11


SFAS No. 123 "Accounting for Stock Based Compensation" ("SFAS 123"), requires
the Company to disclose pro forma information regarding option grants made to
its employees. SFAS 123 specifies certain valuation techniques that produce
estimated compensation charges that are included in the pro forma results below.
These amounts have not been reflected in the Company's Statement of Operations,
because Accounting Principles Board Opinion 25, "Accounting for Stock Issued to
Employees," specifies that no compensation charge arises when the price of the
employees' stock options equal the market value of the underlying stock at the
grant date, as in the case of options granted to the Company's employees

SFAS No. 123 pro forma numbers are as follows for the six-month periods ended
March 31, 2002 and 2001:
                                                     2002         2001
                                                     ----         ----
       Actual net (loss) ....................     (309,052)     (262,409)
       SFAS 123 Compensation Cost ...........       15,986             0
                                                  --------      --------
       Pro forma net income (loss) ..........     (325,038)     (262,409)
                                                  ========      ========
       Pro forma basic and diluted
       net income (loss) per share ..........         (.01)         (.01)
                                                  ========      ========

Under SFAS 123, the fair value of each option grant is estimated on the date of
grant using the Black-Scholes option-pricing model. The following weighted
average assumptions were used:

       Risk free interest rate ....................................    6%
       Expected dividends .........................................    0
       Volatility factor ..........................................  255%
       Weighted average expected
       life of options ............................................    5

The Black-Scholes option valuation model was developed for use in estimating the
fair value of traded options that have no vesting restrictions and are fully
transferable. In addition, option valuation models require the input of highly
subjective assumptions including the expected stock price volatility. Because
the Company's employee stock options have characteristics significantly
different from those of traded options, and because changes in the subjective
input assumptions can materially affect the fair value estimate, in management's
opinion the existing models do not necessarily provide a reliable single measure
of the fair value of the Company's options.

NOTE 12 - EARNINGS PER COMMON SHARE

Earnings per common share are calculated under the provisions of SFAS No. 128,
"Earnings per Share," which established new standards for computing and
presenting earnings per share. SFAS No. 128 requires the Company to report both
basic earnings per share, which is based on the weighted-average number of
common shares outstanding, and diluted earnings per share, which is based on the
weighted-average number of common shares outstanding plus all potential dilutive
common shares outstanding.

                                       12


The weighted average common shares used in the computations of basic earnings
per common share and earnings per common share assuming dilution are as follows:

                                       Three months            Six months
                                      Ended March 31          Ended March 31
                                     2002        2001        2002        2001
                                  ----------  ----------  ----------  ----------
Average common shares
outstanding ....................  23,475,262  25,000,000  23,091,626  25,871,762
Common shares issuable (1) .....       9,017           0       4,434           0
                                  ----------  ----------  ----------  ----------
Average common shares
outstanding assuming
dilution (2) ...................  23,484,279  25,000,000  23,096,060  25,871,762
                                  ==========  ==========  ==========  ==========
---------
(1)   issuable under stock option plans
(2)   not used in earnings per share calculation due to net loss

NOTE 13 - GOING CONCERN

The Company's auditors stated in their reports on the financial statements of
the Company for the years ended September 30, 2001 and 2000 that the Company is
dependent on outside financing and has had losses since inception that raise
substantial doubt about our ability to continue as a going concern. For the
years ended September 30, 2001 and 2000, the Company incurred net annual losses
of $996,474 and $707,689, respectively. Management believes that resources will
be available from private and operating sources in 2002 to continue the
marketing of the Company's products and services. The financial statements do
not include any adjustments relating to the recoverability and classification of
recorded assets, or the amounts and classification of liabilities that might be
necessary in the event the Company cannot continue in existence.

Management has established plans intended to increase the sales of the Company's
products. Management intends to seek new capital from new equity securities
offerings to provide funds needed to increase liquidity, fund growth and
implement its business plan; however, no assurance can be given that the Company
will be able to raise any additional capital.


Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS

The following discussion should be read together with the information contained
in the financial statements and related notes included elsewhere in this report.

We Have Been The Subject Of A Going Concern Opinion From Our Independent
Auditors

Our independent auditors have added explanatory paragraphs to their audit
opinions issued in connection with the 2001 and 2000 financial statements which
states that our Company is dependent on outside financing and has had losses
since inception that raise substantial doubt about our ability to continue as a
going concern. Our financial statements do not include any adjustments that
might result from the outcome of this uncertainty.

                                       13


Critical Accounting Policies

Financial Reporting Release No. 60, which was recently released by the U.S.
Securities and Exchange Commission, encourages all companies to include a
discussion of critical accounting policies or methods used in the preparation of
financial statements. Our consolidated financial statements include a summary of
the significant accounting policies and methods used in the preparation of our
consolidated financial statements.

Management believes the following critical accounting policies affect the
significant judgments and estimates used in the preparation of the financial
statements.

Revenue Recognition - revenues are recognized at the time of shipment of the
respective products and/or services. Our Company includes shipping and handling
fees billed to customers as revenues. Costs of sales include outbound freight.

Use of Estimates

Management's discussion and analysis of financial condition and results of
operations is based upon our consolidated financial statements, which have been
prepared in accordance with accounting principles generally accepted in the
United States of America. The preparation of these financial statements requires
management to make estimates and judgments that affect the reported amounts of
assets, liabilities, revenues, and expenses, and related disclosure of
contingent assets and liabilities. On an ongoing basis, management evaluates
these estimates, including those related to allowances for doubtful accounts
receivable and the carrying value of inventories and long-lived assets.
Management bases these estimates on historical experience and on various other
assumptions that are believed to be reasonable under the circumstances, the
results of which form the basis of making judgments about the carrying value of
assets and liabilities that are not readily apparent from other sources. Actual
results may differ from these estimates under different assumptions or
conditions.

Plan of operation

From 1999 until June 2001, Iceweb operated as a technology hardware and software
distributor business. In June 2001, we acquired the assets of Learning Stream,
Inc. (LSI) in bankruptcy and changed the business model to enable interactive
communication and education on the internet. Our goal is to expand our product
and services offering to take advantage of what we believe to be a rapidly
growing market.

Iceweb's proprietary software, IceSHOW(TM) under development since 1999 and
completed in the 1st quarter 2002, allows us to create Web-ready multimedia
productions very quickly, giving us a tangible competitive advantage in both
time and cost. Our technology integrates audio, video and PowerPoint slides into
a highly interactive, customizable interface.

Additional features can easily be added including closed captioning, indexing,
animation, quizzes and surveys and pay-per-view capabilities.

                                       14


The software ties to a database backend that provides authentication and
reporting.

Our custom services business is another service we offer our customers.
Combining our technology with our experience in producing, packaging and
delivering online presentations allows us to create solutions that meet specific
market demands from e-learning, HR and executive communications and sales and
marketing professionals.

Markets for Products and Services

Iceweb currently has customers in the training, corporate communications and
advertising/marketing segments. We will focus on e-learning solutions while
continuing to support the other segments as opportunities are presented.

Training - A model customer has a widely dispersed audience with regular
training needs; these needs could include compliance with government
regulations, skills updating or educational enhancement. For maximum benefit,
the end user must have a compelling need for the training, such as license
renewal, job progression or degree advancement.

A typical online course would include video or audio with synchronized slides,
plus interactive elements such as registration, quizzes and materials downloads
as well as a database to track progress, compliance and effectiveness. In
addition, training companies, universities or trade associations could charge
students for the course work, creating a new source of ongoing revenue. Iceweb
is providing e-learning solutions for the hotel brands within the Cendant
Corporation training reservations clerks worldwide.

Corporate Communications - A model customer is a corporation with offices
throughout the US or the world. Iceweb's solutions could provide on-demand or
live streaming of executive addresses or earnings calls. They could also be used
by the Human Resources department to provide orientation, introduce new benefits
programs or deliver presentations to employees on compliance matters, such as
sexual harassment training. This can help companies make better use of already
strained budgets, as employees no longer have to take time to attend small or
large group meetings and HR professionals can avoid week-long blocks of travel.
Iceweb has contracts with Cendant companies to provide these services for their
real estate brands.

Advertising & Marketing - Online presentations can be used to sell or market
nearly any industrial or consumer product. As with any direct marketing
technique, the content is of prime importance. However, studies have shown that
by making the message entertaining, combining audio, video and synchronized
slides, retention dramatically increases.

Iceweb has the ability to profitably sell its products and services while
innovating to comply with the leading technology standards. In addition,
Iceweb's education focus will allow it to market is products and services to the
most rapidly growing viewing audience.

                                       15


Technology

The majority of Iceweb's applications are based on client-server technology. The
authoring and content management application software has been developed using a
combination of ColdFusion, Javascript, ASP, VBscript, Java, and Flash. Since a
majority of the processing is done on our server network, the author only needs
a browser to produce and manage presentations. This keeps the need for desktop
processing power to a minimum and allows for future development of enterprise
solutions that can be hosted within a customer's network.

Iceweb is in the process of ensuring its course software code is compliant with
AICC and SCORM computer-based training standards, so that we may integrate its
solutions with those of leading Learning Management System (LMS) providers.
Iceweb's software is designed for Microsoft's Windows operating systems and
applications that use Microsoft's SQL 7 database software.

All Iceweb's software utilizes its original technology in one form or another.
By leveraging the code of existing products, Iceweb decreases new product
development costs, shortens time to market and is therefore able to realize new
revenues from new products quickly.

IceSHOW(TM) is the company's core technology, a multimedia creation and delivery
platform. IceSHOW's powerful feature set and intuitive viewer interface are
designed for ease of use. It offers great flexibility and convenience to
non-technical users. Anyone with encoded media and PowerPoint slides can publish
a multimedia presentation over the Internet very quickly. IceSHOW(TM) further
reduces costs through an online production center. A "wizard" steps users
through the process of uploading and converting existing media components, then
stitching them together seamlessly. There are options for adding a branded
interface and other interactive elements as well. Taking only minutes to
complete (depending on the presentation length), the resulting show is ready for
distribution via the Internet or an intranet.

IceSLIDE(TM) is our PowerPoint-to-Flash format conversion tool. It makes
PowerPoint shows small enough to distribute via the Web or through e-mail.
IceSLIDE(TM) was developed from the slide conversion technology built into
IceSHOW(TM). However, IceSLIDE(TM) is a standalone application that runs on the
viewer's PC. The files it creates can be uploaded into a IceSHOW(TM)
presentation. We currently sell IceSLIDE(TM) directly to graphics professional
via our Web site.

Services

Consulting - Iceweb's consulting staff has years of experience in providing
custom multimedia solutions to all size organizations. Iceweb consulting
services include personalized project management, multimedia development,
synchronization of all media assets, application design and development,
software integration, instructional design, graphic design, foreign language
translations and delivery methods. In addition to our in-house staff, we have a
roster of professionals who can be contracted to provide specific expertise as
needed.

IceSTUDIO(TM) Productions - Iceweb can provide audio/video studio services that
a customer would need to create new audio or video assets or to

                                       16


transform existing media assets for Web use. Services include audio/video
production, live Webcasting, audio/video editing, audio/video encoding,
audio/video transcription, and voiceovers.

o        Encoding - We accept source material in virtually any format to
digitize and encode into a file format that is compatible with the streaming
media architecture being used. In order to produce the best results, an Iceweb
encoding engineer is assigned to each project to analyze critical data and apply
tailored processing to ensure optimum results for that particular clip and data
rates. The end result is video and audio configured properly for transmission
online at the best possible resolution, motion, clarity and system
compatibility, for both dial-up and broadband users.

o        Webcasting - For live productions, we can produce Webcasts from a
studio or from on-location. Webcasts can include audio, video, synchronized
slides and graphics; shows can appear in an interface branded with your
company's look and feel. Interface options include buttons for downloading
additional material, sending a message to the presenter and requesting technical
help. Other available features include advance user registration, user system
detection, password protection, interactive surveys, quizzes and more.

Sales & Marketing Strategy

The potential buyers of Iceweb's products and services are organizations in both
the public and private sectors with large, dispersed audiences of customers,
employees, or partners. Iceweb reaches these buyers directly with its own sales
organization, through telesales and direct marketing. We are also building a
highly focused sales channel to refer or resell Iceweb solutions.

Marketing

Services, by their nature, are unbounded in scope. In order to create demand and
reach our market quickly, we have created several service "products"; in effect,
we have put boundaries around a group of services, which makes them easier to
understand and therefore easier to purchase. No new technology needs to be
created for these "products." Iceweb is simply using the skills and technology
we already have in-house. No additional development is needed to deliver these
"products."

The first set of products is being released under the brand name "IceSHOW(TM)."
These are intended to be pilot programs that whet the appetite and prove the
value proposition. Recognizing that a customer may want to see a deliverable
before making a long-term investment, IceSHOW(TM) programs provide quick
turnaround of a finished online presentation. Custom options are also available.

Each package provides for on-demand viewing and includes a customized interface,
login and registration forms, some level of interactivity, and hosting services
for a specified period of time. They require only minimal amount of labor by
Iceweb, as most of the processes used to create the presentations are automated
by our technology. The products include:

                                       17


o        IceSHOW(TM) e-Learning: Aimed at the educational market, this allows
customers with existing content (video, slides, etc.) to quickly produce an
online training session. It includes an online quiz with real-time results.

o        IceSHOW(TM) HR: For corporate HR managers who wish to contact employees
with new information, for example, details on a new benefits program. It
includes a survey form to poll the viewers.

o        IceSHOW(TM) Exec: This package, designed for local organizations, puts
new video of an executive address online; the video can be shot in our studio or
at the executive's location. It is designed for both internal announcements (to
employees) and external announcements (to shareholders, business partners,
customers, or the media and analyst communities).

o        IceSHOW(TM) WebVideo: Many companies have invested in corporate video
productions. This package allows them to quickly put them online. The customer
submits a video tape or electronic file of the original production. We provide
the encoding and hosting services as well as the customized interface.

We also are launching a Web portal to deliver our customers e-learning courses.
Learningstream.com provides an outlet for customers to sell their online
classes. Iceweb will manage the e-commerce aspects and provide payments to the
course owners, in exchange for a percentage of the revenues. We will include
content that we have produced for our customers as well as existing online
content, or video content that we can convert for Web use. The technology to
support and manage this portal is already in use, as we are currently providing
these services for Fred Pryor Seminars. From an operational standpoint,
Learningstream.com is merely an expansion of this existing service.

Direct mail, email and outbound telemarketing will be used to uncover new
prospects and invite them to view the Iceweb Web site and learn about our
targeted solutions. The site itself is regularly refreshed to include
information relevant to our target audiences.

Iceweb's marketing plan also depends on the strategic application of media
relations. The goal is to not only raise the company's profile, but also
establish Iceweb as an expert source in the streaming media arena. PR and
analyst relations can provide invaluable credibility and can often lead to sales
leads.

In addition, a judicious use of trade shows will be implemented to reach highly
focused audiences in specific market niches.

Sales

Our solutions are sold directly by Iceweb consultative sales personnel. Sales
personnel are assigned target accounts within target markets. Some specific
target markets are:

o        Repeat LearningStream, Inc. customers
o        Training and Marketing Departments of mid- to large-size companies and
trade associations in the DC metropolitan area and select companies in nearby
states

                                       18


o        Audio & Video Production (A/V), Advertising, Promotional and Trade Show
services companies who already create and produce content and wish to deliver it
via the Web o Educational institutions (schools, colleges, universities) that
wish to deliver internal courseware or generate additional revenue through
"e-campus" solutions.

Iceweb products and services are priced competitively based on complexity and
the degree of customization. We have created a number of "pilot" programs with a
strict set of features in order to give prospects a quick deliverable and easy
entry into online multimedia productions. These can be to whet the appetite of
potentially large clients or to close prospects that wish to test the solution's
capabilities in a limited fashion.

Competitive Advantages

Two major Iceweb competitive advantages are its lean business model with low
fixed costs and its favorable margin on products and services. Iceweb's core
competency of digital media production is manifested in its IceSHOW(TM)
technology. It was designed to make our products and services easy and
affordable, the two factors that are key for the Company to fulfill its growth
expectations.

Our technology makes the creation of online multimedia shows easy and affordable
whether Iceweb is doing the work or the customers are using one of Iceweb's
products to do the work themselves. In either case, the cost and complexity of
the development is reduced substantially. And, because Iceweb's products are
easy to understand and use, there is the potential for future distribution by a
sales channel or network of affiliates.

Financial

Since June 2001, working capital to fund our operations was generated from the
proceeds of $539,500 received by us from the private placement of our securities
and also from sales of our product and services to both legacy LSI customers and
new customers.

For the six months and three months ended March 31, 2002, we generated revenues
of $141,171 and $67,686 respectively compared to $489 for each of the
comparative periods in 2001. Our growth drivers accounted for the majority of
the sales increase in both periods; in the six month period ending March 31,
2002 custom services provided $66,209, webcasts provided $59,799 and products
and miscellaneous services accounted for the balance.

Marketing and sales expenses increased for the six and three months ending March
31, 2002 over the same periods in 2001 by $79,007 and $27,965 respectively. This
increase relects continued investment behind the growth drivers, support for new
products and services and a commitment to upgrade the sales and marketing
workforce.

Research and development expenses increased to $43,042 and $16,995 for the six
and three month period ending March 31, 2002 from $0 in each of the same periods
in 2001. This increase is our investment in the development of the IceSHOW
software acquired from LSI.

                                       19


We plan on using this software as the foundation for our product offerings in
the future.

General and administrative expense increased for the six and three months ending
March 31, 2002 over the same periods in 2001 by $18,491 and $12,311
respectively. These expenses include building the infrastructure to support the
business. They also represent our success in operational efficiency initiatives
that focus on the fundamental redesign of work processes to permanently reduce
the Company's overall cost structure.

Total operating expense for the six month ended March 31, 2002 were $345,956,
which includes approximately $139,400 for salaries, $63,662 for contractors, and
$31,750 for office rent.

Overall, our loss per share was $(.01) for both the six months and three months
ending March 31, 2002. This was in line with the loss per share reported for the
same periods of the prior fiscal year. For the balance of this fiscal year we
anticipate that our loss per share may increase.

We expect to generate losses resulting principally from costs incurred in
conjunction with our marketing and sales and research and development
initiatives, and we expect that the costs of these activities will increase as
the implementation of our business plan continues. However, as we continue to
implement our plan of operation, we expect general and administrative expenses
to remain nearly flat and actually decrease as a percentage of sales due to the
process efficiencies we have already put in place.

In order to provide sufficient working capital to fund our ongoing operations we
will be required to raise additional capital to fund these anticipated costs.
There are no assurances that we will be able to obtain the additional capital in
which event our future operations would be materially and adversely affected.

Liquidity and Capital Resources

Since inception, our operating and investing activities have used more cash than
they have generated. Because of the continued need for substantial amounts of
working capital to fund the growth of the business, to meet our commitment for
research funding and to pay our operating expenses, we expect to continue to
experience significant negative operating and investing cash flows for the
foreseeable future. Our existing working capital will not be sufficient to fund
the continued implementation of our plan of operation during the next 12 months
and to meet our capital commitments and general operating expenses. We are
unable to predict at this time the exact amount of additional working capital we
will require, however, in order to provide any additional working capital which
we may require, we will in all likelihood be required to raise additional
capital through the sale of equity or debt securities. We currently have no
commitments to provide us with any additional working capital. If we do not have
sufficient working capital to implement our plan of operation described above,
it is likely that we will cease operations.

                                       20


Cautionary Factors That May Affect Future Results

This report and other written reports and oral statements made from time to time
by the Company may contain so-called "forward-looking statements," all of which
are subject to risks and uncertainties. One can identify these forward-looking
statements by their use of words such as "expects," "plans," "will,"
"estimates," "forecasts," "projects" and other works of similar meaning. One can
identify them by the fact that they do not relate strictly to historical or
current facts. These statements are likely to address the Company's growth
strategy, financial results, and product and development programs. One must
carefully consider any such statement and should understand that many factors
could cause actual results to differ from the Company's forward-looking
statements. These factors include inaccurate assumptions and a broad variety of
other risks and uncertainties, including some that are known and some that are
not. No forward-looking statement can be guaranteed and actual future results
may vary materially.

The Company does not assume the obligation to update any forward-looking
statement. One should carefully evaluate such statements in light of factors
described in the Company's filings with the Securities and Exchange Commission,
especially on Forms 10-K, 10-Q and 8-K. In various filing the Company has
identified important factors that could cause actual results to differ from
expected or historic results. The Company notes these factors for investors as
permitted by the Private Securities Litigation Reform Act of 1995. One should
understand that it is not possible to predict or identify all such factors.
Consequently, the reader should not consider any such list to be a complete list
of all potential risks or uncertainties.

                           Part II - OTHER INFORMATION

Item 1.  Legal Proceedings

         None.

Item 2.  Changes in Securities

         The Company had changes in securities related to the merger as
described in Part I, Note 1 and the private placements as described in Part I,
Note 10.

Item 3.  Defaults upon Senior Securities

         None.

Item 4.  Submission of Matters to a Vote of Security Holders

         None.

Item 5.  Other Information

         None.

                                       21


Item 6.  Exhibits and Reports on Form 8-K

         During the six month period from October 1, 2001 to March 31, 2002, the
Company filed or furnished:

         (a) A current report on Form 8-K filed on December 4, 2001 pertaining
to the share exchange with HealthSpan Sciences, Inc.


                                   SIGNATURES

         In accordance with the requirements of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                             Disease Sciences, Inc.

                                         By: /s/ John R. Signorello
                                                 -------------------
Dated: August 16, 2002                           John R. Signorello,
                                                 Chairman and CEO

                                       22